Why the U.K. is seeing an uptick in COVID-19 cases


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
The United Kingdom is experiencing an uptick in coronavirus cases. It's "tiny" compared to previous spikes, David Leonhardt writes in The New York Times, but he adds that the country will still be "important to watch" in the next few weeks. So, considering the U.K. has had a mostly successful vaccine rollout, why is the increase happening?
The primary culprit is likely the more transmissible Delta variant, first identified in India, that's been spreading in the U.K. The good news is that it appears vaccines hold up pretty well against the mutatated virus, but less so for people who have received only one vaccine dose, which is more common in the U.K. than it is in the United States. The U.K. chose to prioritize first shots early in the rollout, which allowed a wider swath of people to get at least some protection. That was "not necessarily" a mistake, despite the Delta variant changing the game a bit, Leonhardt writes, but it does mean more people — especially younger people who are still in the middle of the vaccination process — have a higher risk of getting infected. Fortunately, about 90 percent of U.K. residents older than 65 have received both doses, and the country "is accelerating second shots for vulnerable people" now, Leonhardt writes.
Dr. Monica Gandhi, who specializes in infectious diseases at the University of California, San Francisco, also pointed out that the U.K. "does a lot of asymptomatic testing" even among the vaccinated population, which may play a role in the increase in cases and help explain why, for now at least, they aren't accompanied by rises in hospitalizations and deaths.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Chris Packham: Is It Time to Break the Law? review
Channel 4 documentary grapples with 'profound' questions about the 'climate apocalypse'
By The Week Staff Published
-
How do we calculate mass deaths?
The Explainer Recent revisions to 9/11 victims, Libyan flood casualties and Covid-19 death toll raise questions over estimates
By Harriet Marsden, The Week UK Published
-
Antimatter isn't immune to gravity, landmark experiment confirms
Speed Read Antimatter is the mysterious evil twin of matter, but new research proves they do have something fundamental in common
By Peter Weber Published
-
How do we calculate mass deaths?
The Explainer Recent revisions to 9/11 victims, Libyan flood casualties and Covid-19 death toll raise questions over estimates
By Harriet Marsden, The Week UK Published
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published